What we do Omkar Speciality Chemicals Ltd manufactures and sells specialty chemicals and intermediates for chemical and allied industries with a focus on molybdenum, cobalt, selenium, and iodine derivatives. |
Founded in 1,983 |
Market share Key player in specialty chemicals with expanding production capacity up to 950 MT annually. |
Problem solved Provides critical specialty chemical raw materials enhancing downstream industrial chemical and pharmaceutical production efficiency. |
Top clients or who we serve Chemical manufacturers, pharmaceutical companies, and allied industries (B2B). |
Key management Pravin S. Herlekar (Chairman & Managing Director). |
Our journey and innovations Founded in 1983, expanded manufacturing capacity significantly, acquired Rishichem Research, entered pharma and fragrance segments, ISO 9001:2008 certified. |
Where we operate Primarily India with limited international sales. |
Top products or what we offer Specialty chemicals including molybdenum, cobalt, selenium, iodine derivatives, pharmaceutical intermediates, flavors, and fragrances. |
Top brands - |
Raw materials needed Raw materials for specialty chemicals production, including molybdenum and cobalt derivatives. |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue is largely recurring from specialty chemical manufacturing contracts. |
Our industry position Established specialty chemical producer with consistent capacity expansions and ISO certifications. |
Financial highlights FY 2020-21 revenue Rs. 46 crore; PAT Rs. 2 crore, indicating turnaround from previous loss. |
Geographical revenue split 44.5 crore from India; 0.58 crore from outside India in FY21. |
Order book - |
Whats driving growth Capacity expansion, diversification into pharma and fragrance segments, and strategic acquisitions. |
Our future plans Focused on capacity enhancements, product diversification, and integration of subsidiaries. |
Our green promise - |
Our people and values 55 employees; emphasis on cordial industrial relations and employee welfare. |
Key challenges ahead Managing financial stability amidst past losses and pandemic-related disruptions. |
Interesting facts Transitioned from proprietorship in 1983 to public limited by 2010; multiple strategic acquisitions and expansions. |
Risks and strategy Addressing non-performing assets, negotiating bank settlements, and enhancing internal controls. |
